Crinetics Pharmaceuticals Inc (CRNX)
SG&A Expense Growth
91.84%
Fiscal year · Period ending:
CRNX SG&A Expense Growth
Latest reported91.84%period ending
Latest reported91.84%period ending
CRNX FY SG&A Growth (YoY) (0.00% → 91.84%)
Latest values, visible window
High-resolution chart · PNG
CRNX sg&a expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 91.8355% | |
| 71.6821% | |
| 37.0335% | |
| 72.8603% | |
| 36.0535% | |
| 33.3383% | |
| 103.0185% | |
| 243.4244% | |
| 26.484% | |
| 0% |